drugset / Trial / NCT04672252

The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy

NCT04672252

Phase 2/3 Completed 100 enrolled NYU Langone Health Orcosa Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the effects of administering CBD to control post-operative pain in patients undergoing shoulder arthroscopy. Secondly, the purpose will be to evaluate the effectiveness of CBD in comparison with opioid therapy for post-operative pain.

Timeline

Start
2020-12-01
Primary completion
2021-12-16
Completion
2022-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 25 mg Oral
Subject Cannabidiol Other / unclassified 50 mg Oral

Indications